1. Emami S, Falahati M, Banifatemi A, Amanlou M, Shafiee A. (E)- and (Z)-1,2,4-Triazolylchromanone oxime ethers as conformationally constrained antifungals. Bioorganic & Medicinal Chemistry. 2004;12(15):3971-3976.DOI:10.1016/j.bmc.2004.06.010.
2. Özyurek M, Akpınar D, Bener M, Türkkan B, et al. Novel oxime based flavanone, naringin-oxime: Synthesis, characterization and screening for antioxidant activity. Chemico-Biological Interactions.2014;212:40-46.
3. Kocyigit A, Koyuncu I, Dikilitas M, Bahadori F, Turkkan B. Cytotoxic, genotoxic and apoptotic effects of naringenin-oxime relative to naringenin on normal and cancer cell lines. Asian Pacific Journal of Tropical Biomedicine. 2016;6(10):872-880.
4. Wang TC, Chen IL, Lu CM, Kuo DH, Liao CH. Synthesis, and cytotoxic and antiplatelet of oxime- and methyloxime-containing flavone, isoflavone, and xanthone derivatives. Chemistry&Biodiversity.2005;2:253-263.DOI:10.1002/cbdv.200590008.
5. Schepetkin IA, Plotnikov MB, Khlebnikov AI, Plotnikova TM, Quinn MT. Oximes: novel therapeutics with anticancer and anti-inflammatory potential. biomolecules. 2021;11(6):777. DOI: 10.3390/biom11060777.
6. Kozłowska J, Potaniec B, Żarowska B, AniołM. Synthesis and biological activity of novel O-Alkyl derivatives of naringenin and their oximes. Molecules.2017;22(9):1485. DOI: 10.3390/molecules22091485.
7. Latif AD, Gonda T, Vágvölgyi M, KúszN, et al. Synthesis and in vitro antitumor activity of naringenin oxime and oxime ether derivatives.International Journal of Molecular Sciences. 2019;20(9):2184. DOI: 10.3390/ijms20092184.
8. Radhakrishnan SK, Shimmon RG, ConnC, BakerAT. Evaluation of novel chalcone oximes as inhibitors of tyrosinase and melanin formation in B16 cells. Arch Pharm (Weinheim). 2016;349(1):20-29. DOI: 10.1002/ardp.201500298.
9. Koyuncu I, Kocyigit A, Gonel A, Arslan E, Durgun M. The protective effect of naringenin-oxime on cisplatin induced toxicity in rats. Biochemistry Research International.2017:9478958. DOI: 10.1155/2017/9478958.
10. Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports.2017;7(1):42717. DOI:10.1038/srep42717.
11. Горишний В.Я., Матийчук В.С. Синтез, физико-химические свойства, биоподобие и противоопухолевая активность эфиров и амидов 2-[5-(4-бромбензилиден)-4-оксо-2-тиоксотиазолидин-3-ил]-3-метилбутановой кислоты // Журнал органической химии.2021. Т. 57. № 1. С. 35-42. DOI: 10.31857/S0514749221010043.
12. Шумадалова А.В., Виноградова Ю.И., Хузин Д.Р. Синтез и in silico прогноз фармакологической активности новых гидразонопроизводных тиетансодержащего пиримидина // Инновации в медицине и фармации. 2023. С. 600-603.
13. Сивцева О.С. Синтез и характеристики оксимагесперетина // Современные проблемы науки и образования. 2015. № 1-1. С. 1868.
14. Поздняков Д.И., Аджиахметова С.Л., Червонная Н.М., Оганесян Э.Т. Химическая модификация ex planta флавоноида флоридзина реакцией оксимирования и оценка его нейропротекторной активности // Башкирский химический журнал. 2023. Т.30. № 4. С. 17-21. DOI: 10.17122/bcj-2023-4-17-21.
15. Wang W, Zhao C, Zhu D, Gong G, Du W. Inhibition of amyloid peptide fibril formation by gold-sulfur complexes. Journal of Inorganic Biochemistry. 2017;171:1-9. DOI: 10.1016/j.jinorgbio.2017.02.021.
16. SathiyaPriya C, Vidhya R, Kalpana K, Anuradha CV. Indirubin-3’-monoxime prevents aberrant activation of GSK-3β/NF-κB and alleviates high fat-high fructose induced Aβ-aggregation, gliosis and apoptosis in mice brain.International Immunopharmacology. 2019;70:396-407. DOI: 10.1016/j.intimp.2019.02.053.
17. Zhao XZ, Liu F, Burke TR Jr. Application of post solid-phase oxime ligation to fine-tune peptide-protein interactions. Molecules. 2020;25(12):2807. DOI: 10.3390/molecules25122807.
18. Chen GF, Xu TH, Yan Y, Zhou YR, et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacologica Sinica. 2017;38(9):1205-1235. DOI: 10.1038/aps.2017.28.